콘텐츠로 건너뛰기
Merck
  • Bis dihydropyrimidine: synthesis and antimycobacterial activity.

Bis dihydropyrimidine: synthesis and antimycobacterial activity.

Journal of enzyme inhibition and medicinal chemistry (2010-06-30)
Mohamed Ashraf Ali, Elumalai Manogaran, Jeyabalan Govindasamy, Velmurugan Sellappan, Suresh Pandian
초록

A series of bis dihydropyrimidine compounds were synthesised by reacting dapsone with acetylacetoacetate to produce N1-4-[4-(2-oxopropylcarboxamido) phenylsulphonyl] phenyl-3-oxobutanamide, then treated with guanidine hydrochloride and an appropriate aldehyde with a catalytic amount of p-toluene sulphonic acid (PTSA) in the presence of methanol to afford the title compounds. The synthesised compounds were evaluated for their antimycobacterial activity against Mycobacterium tuberculosis H(37)Rv and isoniazid (INH) resistant M. tuberculosis. Among the synthesised compounds, compound N5-(4-4-[6-(4-fluorophenyl)-2-imino-4-methyl-1,2,3,4-tetrahydro-5-pyrimidinylcarboxamido]phenylsulphonylphenyl)-6-(4-fluorophenyl)-2-imino-4-methyl-1,2,3,4-tetrahydro-5-pyrimidine carboxamide (3g) was found to be the most promising compound with activity against M. tuberculosis H(37)Rv and INH resistant M. tuberculosis with a minimum inhibitory concentration (MIC) between 0.08 and 0.10 μM.

MATERIALS
제품 번호
브랜드
제품 설명

Sigma-Aldrich
Sodium p-toluenesulfonate, 95%
Sigma-Aldrich
p-Toluenesulfonic acid monohydrate, ACS reagent, ≥98.5%
Sigma-Aldrich
p-Toluenesulfonic acid monohydrate, ReagentPlus®, ≥98%
Sigma-Aldrich
Silver p-toluenesulfonate, ≥99%